Cargando…

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols

Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents, and it is also a potentially painful and debilitating condition. To date, no specific studies have prospectively evaluated the efficacy of its treatment and no robust standa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Fede, Olga, Canepa, Federica, Panzarella, Vera, Mauceri, Rodolfo, Del Gaizo, Carmine, Bedogni, Alberto, Fusco, Vittorio, Tozzo, Pietro, Pizzo, Giuseppe, Campisi, Giuseppina, Galvano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392050/ https://www.ncbi.nlm.nih.gov/pubmed/34444181 http://dx.doi.org/10.3390/ijerph18168432

Ejemplares similares

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series
por: Di Fede, Olga, et al.
Publicado: (2022)

The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention
por: Di Fede, Olga, et al.
Publicado: (2018)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)
por: Fusco, Vittorio, et al.
Publicado: (2022)

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis
por: Campisi, Giuseppina, et al.
Publicado: (2021)

Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study
por: Mauceri, Rodolfo, et al.
Publicado: (2018)

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023)

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021)

Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023)

Diagnostic delay of oral squamous cell carcinoma and the fear of diagnosis: A scoping review
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
por: Oteri, Giacomo, et al.
Publicado: (2018)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
por: Fusco, Vittorio, et al.
Publicado: (2018)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Migliorati, Cesar Augusto
Publicado: (2022)

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022)

Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: a rare case report and review of the literature
por: Capocasale, Giorgia, et al.
Publicado: (2017)

MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series
por: Mauceri, Rodolfo, et al.
Publicado: (2023)

Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)
por: Bedogni, A, et al.
Publicado: (2012)

Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ)
por: Jowett, Adam, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report
por: Samieirad, Sahand, et al.
Publicado: (2021)

Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?
por: Costa, Renato Patrizio, et al.
Publicado: (2019)

Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives
por: Cristaldi, Marta, et al.
Publicado: (2019)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
por: Dalle Carbonare, Luca, et al.
Publicado: (2021)

Improving the cancer adult patient support network (iCAN): a pilot study on a communication model and modified focus group
por: Campisi, Giuseppina, et al.
Publicado: (2023)

Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Nica, Diana Florina, et al.
Publicado: (2021)

Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study
por: Varoni, Elena M., et al.
Publicado: (2021)

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021)

Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review
por: Gkouveris, Ioannis, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
por: Rosales, Hemil Dario, et al.
Publicado: (2023)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
por: Shibahara, Takahiko
Publicado: (2019)

Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
por: Okuyama, Kohei, et al.
Publicado: (2021)

Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
por: Gaudet, Camille, et al.
Publicado: (2022)

Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies
por: Muttanahally, Kavya Shankar, et al.
Publicado: (2023)

Low Frequency of Human Papillomavirus in Strictly Site-Coded Oral Squamous Cell Carcinomas, Using the Latest NHI/SEER-ICD Systems: A Pilot Observational Study and Critical Review
por: Panzarella, Vera, et al.
Publicado: (2021)

Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England
por: Sturrock, Andrew, et al.
Publicado: (2019)

New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures
por: Laimer, Johannes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u1pq0ebheue93i2k67iduarskq